PMGC Holdings Inc. (ELAB)
NASDAQ: ELAB · Real-Time Price · USD
5.25
-0.32 (-5.75%)
At close: Jan 9, 2026, 4:00 PM EST
5.13
-0.12 (-2.29%)
Pre-market: Jan 12, 2026, 4:25 AM EST
PMGC Holdings Employees
As of December 31, 2024, PMGC Holdings had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees decreased by 15 or -83.33% compared to the previous year.
Employees
3
Change (1Y)
-15
Growth (1Y)
-83.33%
Revenue / Employee
$95,316
Profits / Employee
-$2,233,290
Market Cap
976.66K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3 | -15 | -83.33% |
| Dec 31, 2023 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ELAB News
- 5 days ago - PMGC Holdings Inc. Announces Strategic Share Acquisition in Micro Modular Reactor (MMR) Focused Nuclear Energy Company, Nuclea Energy Inc. - GlobeNewsWire
- 6 days ago - PMGC Holdings Inc. Announces Reverse Stock Split Effective January 6, 2026 - GlobeNewsWire
- 9 days ago - PMGC Holdings Inc. Announces Anticipated Reverse Stock Split - GlobeNewsWire
- 20 days ago - AGA Precision Systems LLC Achieves Globally Recognized AS9100 Certification for Aerospace, Defense, and Space Manufacturing, Exploring Future Humanoid Robotics Integration - GlobeNewsWire
- 25 days ago - NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries - GlobeNewsWire
- 5 weeks ago - PMGC Holdings Inc. [Nasdaq: ELAB] Congratulates General Enterprise Ventures, Inc. [NYSE: CITR] on Its Uplisting to the NYSE American, Highlights Equity Stake - GlobeNewsWire
- 2 months ago - PMGC Holdings Inc. Announces Over $711,000.00 in Sales Backlog at AGA Precision Systems LLC and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Northstrive Biosciences Announces Completion of Phase II of AI Development Program with YuvaBio Using MitoNova™ Artificial Intelligence (AI) Platform to Develop Therapies for Obesity and Cardiometabolic Diseases - GlobeNewsWire